Clincosm LogoSign in Get a demo

APPSPIRE App in Preventing Students From Smoking

Sponsor
M.D. Anderson Cancer Center (Other)
Overall Status
Completed
CT.gov ID
NCT01967082
Collaborator
National Cancer Institute (NCI) (NIH), National Institute on Drug Abuse (NIDA) (NIH)
30
Enrollment
2
Locations
1
Arm
74.7
Actual Duration (Months)
15
Patients Per Site
0.2
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This trial studies how well APPSPIRE, a smartphone app, works in preventing students from smoking. Technology-driven intervention programs, such as the APPSPIRE app, have the potential to increase access to health behavior treatments and therapies, such as tobacco cessation support, and provide effective prevention messaging.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: APPSPIRE
  • Behavioral: Focus Group
  • Other: Survey Administration
 N/A

Detailed Description

PRIMARY OBJECTIVES:

  1. Develop a prototype of the APPSPIRE (phone application [app] of a smoking prevention interactive experience).

  2. At post assessment, students enrolled in the study will qualitatively provide information about the usability and usefulness for the prevention and cessation sites.

  3. Investigate frequency of use of and exposure to APPSPIRE modules via an objective measure of general use.

  4. Investigate how feasible the program will be. V. Obtain a maintained use of APPSPIRE with high completeness and extent of completion.

  5. Evaluate change in stage of change from baseline to about 1 and 4-month follow-ups among participants.

OUTLINE:

Participants attend an audio-taped focus group over 1 hour and are given the APPSPIRE app. After 1 and 4 months of using the app, participants complete a telephone survey over 1 hour to discuss how they liked the app and its usefulness.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
APPSPIRE: Expanding the Reach of an Innovative Tobacco Control Program for Youth
Actual Study Start Date :
Oct 16, 2013
Actual Primary Completion Date :
Jan 8, 2020
Actual Study Completion Date :
Jan 8, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Prevention (focus group, APPSPIRE app, survey)

Participants attend an audio-taped focus group over 1 hour and are given the APPSPIRE app. After 1 and 4 months of using the app, participants complete a telephone survey over 1 hour to discuss how they liked the app and its usefulness.

Behavioral: APPSPIRE
Given APPSPIRE app
Other Names:
  • APPSPIRE Smartphone Application; APPSPIRE Smartphone App; APPSPIRE App; APPSPIRE Application

    • Behavioral: Focus Group
    Attend focus group

    Other: Survey Administration
    Complete survey

    Outcome Measures

    Primary Outcome Measures

    1. Frequency of APPSPIRE application (app) use [Up to 4 months]

      Will be measured in minutes per day and with descriptive statistics. Will measure using mean, median and standard deviation for continuous variables.

    2. The Feasibility of the tobacco control program. [Up to 4 months]

      Feasibly will be measured by multiplying the variable of two concepts: ease of use and ability to fit the program into routine schedules.

    3. The Completeness with the Percentages of Participants surveyed. [Up to 4 months]

      Completeness will be measured as the percentage of participants who continue to use AppSPIRE until the 4 month follow up survey.

    4. The extent of completion for the modules AppSPIRE. [Up to 4 months]

      The extent of completion includes the various modules of AppSPIRE. High extent of completion is obtained if 75% of the participants have completed all modules of AppSPIRE.

    5. The Stages of the Change Scale [Baseline up to 4 months]

      A validated measure, The Stages of Change Scale, will be used to clarify smokers into 3 categories: pre-contemplation, contemplation and preparation.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 24 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Student at Houston Community College (HCC)

    • Speak and read English

    • Own an iPhone

    • Be enrolled in at least one class at HCC

    • Provide current contact information

    • Smoke 1 or more cigarettes a day (cessation group)

    • Have access to the internet (cessation and prevention/advocacy groups)

    • Evidence of smoking susceptibility as defined by the Smoking Susceptibility Scale

    Exclusion Criteria:

    • Does not plan to continue as a student at their campus sometime during the year of the study (cessation and prevention/advocacy groups)

    • Current tobacco use (prevention/advocacy group)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Houston Community College Houston Texas United States 77002
    2 M D Anderson Cancer Center Houston Texas United States 77030

    Sponsors and Collaborators

    • M.D. Anderson Cancer Center
    • National Cancer Institute (NCI)
    • National Institute on Drug Abuse (NIDA)

    Investigators

    • Principal Investigator: Alexander V Prokhorov, M.D. Anderson Cancer Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    M.D. Anderson Cancer Center
    ClinicalTrials.gov Identifier:
    NCT01967082
    Other Study ID Numbers:
    • 2013-0369
    • NCI-2018-03054
    • 2013-0369
    • P30CA016672
    • R41DA035012
    First Posted:
    Oct 22, 2013
    Last Update Posted:
    Jan 14, 2020
    Last Verified:
    Jan 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Jan 14, 2020